Alerts will be sent to your verified email
Verify Email
BAFNAPH
|
Bafna Pharma
|
iStreet Network
|
Trident Lifeline
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 5.48 % | 31.52 % |
|
5yr average Equity Multiplier
|
3.77 | -1.13 | 2.03 |
|
5yr Average Asset Turnover Ratio
|
0.42 | 0.21 | 0.82 |
|
5yr Avg Net Profit Margin
|
-36.55 % | 1.44 % | 16.21 % |
|
Price to Book
|
6.46 | 200.73 | 3.98 |
|
P/E
|
34.18 | 66.77 | 16.92 |
|
5yr Avg Cash Conversion Cycle
|
0.18 Days | 22.21 Days | 61.09 Days |
|
Inventory Days
|
87.65 Days | 0.0 | 72.84 Days |
|
Days Receivable
|
132.64 Days | 220.87 Days | 86.3 Days |
|
Days Payable
|
210.48 Days | 39.73 Days | 122.66 Days |
|
5yr Average Interest Coverage Ratio
|
-5.68 | -107.0 | 14.53 |
|
5yr Avg ROCE
|
-11.61 % | -79.54 % | 26.3 % |
|
5yr Avg Operating Profit Margin
|
-21.98 % | 1.54 % | 16.98 % |
|
5 yr average Debt to Equity
|
1.41 | -1.09 | 0.47 |
|
5yr CAGR Net Profit
|
12.0 % | n/a | 24.36 % |
|
5yr Average Return on Assets
|
-16.11 % | -113.8 % | 13.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.0 % | 46.24 % | 62.85 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 6.9 % |
|
Change in Promoter Holding (3 Yrs)
|
-15.0 % | 0.04 % | -7.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bafna Pharma
|
iStreet Network
|
Trident Lifeline
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|